Yao‐Jen Liang

1.4k total citations
55 papers, 1.2k citations indexed

About

Yao‐Jen Liang is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Epidemiology. According to data from OpenAlex, Yao‐Jen Liang has authored 55 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 16 papers in Endocrinology, Diabetes and Metabolism and 11 papers in Epidemiology. Recurrent topics in Yao‐Jen Liang's work include Advanced Glycation End Products research (10 papers), Metabolism, Diabetes, and Cancer (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Yao‐Jen Liang is often cited by papers focused on Advanced Glycation End Products research (10 papers), Metabolism, Diabetes, and Cancer (6 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (6 papers). Yao‐Jen Liang collaborates with scholars based in Taiwan, United States and India. Yao‐Jen Liang's co-authors include Han‐Min Chen, Chi‐Shun Tu, Yeong-Der Yao, Jyh‐Gang Leu, Chi‐Feng Hung, Ling‐Ping Lai, Wen‐Mein Wu, Yi-Jung Chen, Chia‐Hsiang Hsueh and Dee Pei and has published in prestigious journals such as ACS Nano, PLoS ONE and Scientific Reports.

In The Last Decade

Yao‐Jen Liang

52 papers receiving 1.1k citations

Peers

Yao‐Jen Liang
Le Kuai China
Liying Qiu China
Yifan Yang China
Litai Jin China
Qian Xie China
Ashwani Mittal India
Jiandong Luo China
Mohammad Reza Mehrabi Iran
Qian Cai China
Le Kuai China
Yao‐Jen Liang
Citations per year, relative to Yao‐Jen Liang Yao‐Jen Liang (= 1×) peers Le Kuai

Countries citing papers authored by Yao‐Jen Liang

Since Specialization
Citations

This map shows the geographic impact of Yao‐Jen Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yao‐Jen Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yao‐Jen Liang more than expected).

Fields of papers citing papers by Yao‐Jen Liang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yao‐Jen Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yao‐Jen Liang. The network helps show where Yao‐Jen Liang may publish in the future.

Co-authorship network of co-authors of Yao‐Jen Liang

This figure shows the co-authorship network connecting the top 25 collaborators of Yao‐Jen Liang. A scholar is included among the top collaborators of Yao‐Jen Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yao‐Jen Liang. Yao‐Jen Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
4.
Li, Pengfei, Chi‐Hsiang Chung, Chieh‐Hua Lu, et al.. (2022). Association of dipeptidyl peptidase-4 inhibitor use and the risk of asthma development among type 2 diabetes patients. Therapeutic Advances in Respiratory Disease. 16. 2673714648–2673714648. 2 indexed citations
5.
Li, Pengfei, et al.. (2022). The Association between Human Epididymis Secretory Protein 4 and Metabolic Syndrome. Journal of Clinical Medicine. 11(9). 2362–2362. 2 indexed citations
6.
Leu, Jyh‐Gang, et al.. (2021). Hydralazine attenuates renal inflammation in diabetic rats with ischemia/reperfusion acute kidney injury. European Journal of Pharmacology. 910. 174468–174468. 14 indexed citations
7.
Wu, Chung‐Ze, Chieh‐Hua Lu, Jiunn‐Diann Lin, et al.. (2020). Relationships between white blood cell count and insulin resistance, glucose effectiveness, and first- and second-phase insulin secretion in young adults. Medicine. 99(43). e22215–e22215. 7 indexed citations
8.
Lee, Shih-Yi, et al.. (2020). Soluble Dipeptidyl Peptidase-4 Induces Fibroblast Activation Through Proteinase-Activated Receptor-2. Frontiers in Pharmacology. 11. 552818–552818. 22 indexed citations
9.
Hsu, Chun‐Hsien, Chang‐Hsun Hsieh, Chung‐Ze Wu, et al.. (2017). High normotension is associated with future metabolic syndrome but not cardiovascular disease. Medicine. 96(25). e7227–e7227. 1 indexed citations
10.
Lee, Chien-Hsing, Chang‐Hsun Hsieh, Yi‐Jen Hung, et al.. (2016). The differences of metabolic syndrome in elderly subgroups: A special focus on young-old, old-old and oldest old. Archives of Gerontology and Geriatrics. 65. 92–97. 20 indexed citations
11.
Chen, Yen‐Lin, Dee Pei, Yi‐Chuan Cheng, et al.. (2015). The neuroprotective role of metformin in advanced glycation end product treated human neural stem cells is AMPK-dependent. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1852(5). 720–731. 71 indexed citations
12.
Hsu, Chun‐Hsien, I‐Chao Liu, Chang‐Hsun Hsieh, et al.. (2015). Mean arterial pressure is better at predicting future metabolic syndrome in the normotensive elderly: A prospective cohort study in Taiwan. Preventive Medicine. 72. 76–82. 20 indexed citations
13.
Li, Pengfei, Chang‐Hsun Hsieh, Yi‐Jen Hung, et al.. (2015). The relationships between hematogram and metabolic syndrome in elderly subgroups: A Taiwan cohort study. Archives of Gerontology and Geriatrics. 63. 59–66. 7 indexed citations
14.
Lin, Jiun‐Tsai, Han‐Min Chen, Chih‐Hsien Chiu, & Yao‐Jen Liang. (2014). AMP-activated protein kinase activators in diabetic ulcers: from animal studies to Phase II drugs under investigation. Expert Opinion on Investigational Drugs. 23(9). 1253–1265. 24 indexed citations
15.
16.
Liang, Yao‐Jen, et al.. (2013). L-165,041, troglitazone and their combination treatment to attenuate high glucose-induced receptor for advanced glycation end products (RAGE) expression. European Journal of Pharmacology. 715(1-3). 33–38. 12 indexed citations
17.
Chen, Han‐Min, et al.. (2012). Topical treatment with anti-oxidants and Au nanoparticles promote healing of diabetic wound through receptor for advance glycation end-products. European Journal of Pharmaceutical Sciences. 47(5). 875–883. 125 indexed citations
18.
Chang, Hsiao‐Ting, et al.. (2012). Asymptomatic bacteriuria among the elderly residents of long-term care facilities in Taiwan. Age and Ageing. 41(6). 795–798. 6 indexed citations
19.
Leu, Jyh‐Gang, Han‐Min Chen, Wen‐Mein Wu, et al.. (2011). The effects of gold nanoparticles in wound healing with antioxidant epigallocatechin gallate and α-lipoic acid. Nanomedicine Nanotechnology Biology and Medicine. 8(5). 767–775. 211 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Le Kuai Breakdown of academic impact, for papers by Liying Qiu Breakdown of academic impact, for papers by Yifan Yang Breakdown of academic impact, for papers by Litai Jin Breakdown of academic impact, for papers by Qian Xie Breakdown of academic impact, for papers by Ashwani Mittal Breakdown of academic impact, for papers by Jiandong Luo Breakdown of academic impact, for papers by Mohammad Reza Mehrabi Breakdown of academic impact, for papers by Qian Cai
Rankless by CCL
2026